Ballew Advisors, Inc Johnson & Johnson Transaction History

Ballew Advisors, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $15,579 - $17,000	-107 Reduced 7.86%	1,255 $196,000
Q3 2023 Oct 06, 2023	SELL	$155.75 - $174.48 $46,725 - $52,344	-300 Reduced 18.05%	1,362 $212,000
Q1 2023 Jul 06, 2023	BUY	$151.05 - $180.26 $24,772 - $29,562	164 Added 10.95%	1,662 $257,000
Q4 2021 Jan 26, 2022	BUY	$155.93 - $173.01 $15,593 - $17,301	100 Added 7.15%	1,498 $251,000
Q2 2021 Jul 15, 2021	SELL	$159.48 - $171.07 $222,953 - $239,155	-1,398 Reduced 50.0%	1,398 $237,000
Q1 2021 Apr 13, 2021	BUY	$153.07 - $170.48 $230,829 - $257,083	1,508 Added 117.08%	2,796 $456,000
Q4 2020 Jan 13, 2021	BUY	$137.11 - $157.38 $176,597 - $202,705	1,288 New	1,288 $205,000
Q1 2020 Jul 10, 2020	SELL	$111.14 - $153.99 $154,262 - $213,738	-1,388 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$127.5 - $146.44 $176,970 - $203,258	1,388 New	1,388 $202,000
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $196,544 - $236,544	-1,600 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$119.4 - $131.76 $34,387 - $37,946	-288 Reduced 15.25%	1,600 $194,000
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $500 - $592	4 Added 0.21%	1,888 $242,000
Q4 2017 Jan 30, 2018	BUY	$131.22 - $143.62 $247,218 - $270,580	1,884	1,884 $263,000

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ballew Advisors, Inc with notifications on news.